The addictive potential of the painkillers has fueled an opioid epidemic that has caused more than half a million overdose deaths in the United States over a period spanning more than two decades.
https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersFDAlogo5-23-2022.webp7401200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-12-20 01:48:552023-12-20 09:15:12US FDA approves first test to identify opioid use addiction risk
